Gray and white matter volume changes in early RRMS - A 2-year longitudinal study

被引:146
作者
Tiberio, M
Chard, DT
Altmann, DR
Davies, G
Griffin, CM
Rashid, W
Sastre-Garriga, J
Thompson, AJ
Miller, DH
机构
[1] Inst Neurol, NMR Res Grp, NMR Res Unit, Dept Neuroinflammat, London WC1N 3BG, England
[2] UCL, Dept Med Stat, Sch Hyg & Trop Med, London, England
[3] Univ Padua, Dept Neurol & Psychiat Sci, Padua, Italy
关键词
D O I
10.1212/01.WNL.0000154526.22878.30
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Brain atrophy, in excess of that seen with normal aging, has been observed early in the clinical course of relapsing-remitting multiple sclerosis ( RRMS). Previous work has suggested that at this stage of the disease, gray matter ( GM) atrophy progresses more rapidly than the white matter ( WM) atrophy. Objectives: To characterize the evolution of GM and WM volumes over 2 years, and their associations with lesion loads in a cohort of patients with clinically early RRMS. Methods: Twenty-one patients with RRMS ( mean age 37.5 years, mean disease duration from symptom onset 2.1 years) and 10 healthy control subjects ( mean age 37.1 years) were studied. Tissue volumes, as fractions of total intracranial volumes, were estimated at baseline and 1- and 2- year follow-up. Brain parenchymal fractions ( BPF), GM fractions ( GMF), and WM fractions ( WMF) were estimated. In subjects with MS, brain lesion loads were determined on conventional T2- weighted along with pre- and post- gadolinium ( Gd) enhanced T1- weighted images at each timepoint. Results: A decrease in GMF was observed in subjects with MS vs normal controls over the 2 years of the study ( mean - 2.1% vs -1.0%, p = 0.044), while no change was seen in WMF over the same period ( mean -0.09% vs + 0.09%, p = 0.812). However, when the MS cohort was divided in half, dependent upon change in Gd-enhancing lesion load over 2 years ( n = 20), a decrease in WMF was seen in the group ( n = 10) with the largest decline in Gd volume, whereas WMF increased in the other half ( n = 10) concurrent with a net increase in volume of Gd-enhancing lesions ( difference between groups: p = 0.034). Conclusions: Increasing gray matter but not white matter ( WM) atrophy was observed early in the clinical course of relapsing- remitting multiple sclerosis. Fluctuations in inflammatory WM lesions appear to be related to volume changes in WM over this time period.
引用
收藏
页码:1001 / 1007
页数:7
相关论文
共 63 条
[11]   Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology [J].
Bruck, W ;
Bitsch, A ;
Kolenda, H ;
Bruck, Y ;
Stiefel, M ;
Lassmann, H .
ANNALS OF NEUROLOGY, 1997, 42 (05) :783-793
[12]   Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis [J].
Chard, DT ;
Griffin, CM ;
Rashid, W ;
Davies, GR ;
Altmann, DR ;
Kapoor, R ;
Barker, GJ ;
Thompson, AJ ;
Miller, DH .
MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (04) :387-391
[13]   The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study [J].
Chard, DT ;
Brex, PA ;
Ciccarelli, O ;
Griffin, CM ;
Parker, GJM ;
Dalton, C ;
Altmann, DR ;
Thompson, AJ ;
Miller, DH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (11) :1551-1554
[14]   Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis [J].
Chard, DT ;
Griffin, CM ;
McLean, MA ;
Kapeller, P ;
Kapoor, R ;
Thompson, AJ ;
Miller, DH .
BRAIN, 2002, 125 :2342-2352
[15]   The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology [J].
Chard, DT ;
Parker, GJM ;
Griffin, CMB ;
Thompson, AJ ;
Miller, DH .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 15 (03) :259-267
[16]   Brain atrophy in clinically early relapsing-remitting multiple sclerosis [J].
Chard, DT ;
Griffin, CM ;
Parker, GJM ;
Kapoor, R ;
Thompson, AJ ;
Miller, DH .
BRAIN, 2002, 125 :327-337
[17]   Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis [J].
Ciccarelli, O ;
Giugni, E ;
Paolillo, A ;
Mainero, C ;
Gasperini, C ;
Bastianello, S ;
Pozzilli, C .
EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 (04) :455-459
[18]   Thalamic neurodegeneration in multiple sclerosis [J].
Cifelli, A ;
Arridge, M ;
Jezzard, P ;
Esiri, MM ;
Palace, J ;
Matthews, PM .
ANNALS OF NEUROLOGY, 2002, 52 (05) :650-653
[19]   Development of a multiple sclerosis functional composite as a clinical trial outcome measure [J].
Cutter, GR ;
Baier, ML ;
Rudick, RA ;
Cookfair, DL ;
Fischer, JS ;
Petkau, J ;
Syndulko, K ;
Weinshenker, BG ;
Antel, JP ;
Confavreux, C ;
Ellison, GW ;
Lublin, F ;
Miller, AE ;
Rao, SM ;
Reingold, S ;
Thompson, A ;
Willoughby, E .
BRAIN, 1999, 122 :871-882
[20]   Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes [J].
Dalton, CM ;
Chard, DT ;
Davies, GR ;
Miszkiel, KA ;
Altmann, DR ;
Fernando, K ;
Plant, GT ;
Thompson, AJ ;
Miller, DH .
BRAIN, 2004, 127 :1101-1107